Isolation Of Fetal Cells Using Facs
Patent No. EP4242652 (titled "Isolation Of Fetal Cells Using Facs") was filed by Arcedi Biotech APS on Jun 8, 2020. The application was issued on Jan 15, 2025.
Patent Summary
Automated method for isolating fetal cells from maternal blood samples using fluorescence-activated cell sorting (FACS) and machine learning-based classification. The method involves enriching fetal cells using endothelial markers, followed by FACS-based sorting and single-cell analysis using a classifier that combines multiple parameters, including scatter and fluorescence signals. The isolated fetal cells can be used for genetic analysis to detect fetal abnormalities.
Patent Family
Patent Oppositions
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Dossier Documents
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents
EP4242652
- Application Number
- EP23183492A
- Filing Date
- Jun 8, 2020
- Status
- Granted And Under Opposition
- Dec 13, 2024
- Publication Date
- Jan 15, 2025
- External Links
- Slate, Register , Google Patents